LA VACUNACIÓN CONTRA EL VIRUS DEL PAPILOMA HUMANO EN HOMBRES QUE TIENEN RELACIONES SEXUALES CON HOMBRES

Oscar González-Carpio Paredes

Resumen


Introducción: Un parte importante de hombres que tienen sexo con otros hombres son infectados por múltiples tipos del Virus del Papiloma Humano, en mayor proporción con los tipos 16 y 18, causantes del 80% de los cánceres anales. Los objetivos de este estudio son evaluar si los hombres homosexuales podrían beneficiarse de la vacunación contra el virus del papiloma humano, describir la aceptabilidad de la vacuna y conocer los programas de vacunación nacionales que incluyan a este grupo de riesgo. Métodos: Se realiza una revisión sistemática en PubMed. Conclusiones: Los hombres homosexuales podrían beneficiarse de programas de vacunación contra el virus del papiloma humano, en mayor medida en aquellos países donde solo las niñas son vacunadas rutinariamente.

Palabras clave


Inmunización; Papiloma; Homosexualidad masculina; Neoplasia del ano; Aceptación de Atención de Salud;

Citas


Koutsky L. (1997): “Epidemiology of genital human papillomavirus infection”. The American journal of medicine, 102(5-A), 3-8.

Lowy DR, Schiller JT. (2006): “Prophylactic human papillomavirus vaccines”, Journal clinical investigation, 116(5), 1167-1173.

Lacey ChJ, Lowndes CM, Shah KV. (2006): “Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease”, Vaccine, 24S3, S3/35 –S3/41.

Parkin DM, Bray F. (2006): “The burden of HPV-related cancers”, Vaccine, 24S3, S3/11–S3/25.

Palefsky JM and Rubi M. (2009): “The Epidemiology of Anal Human Papillomavirus and Related Neoplasia”. Obstetrics and Gynaecology Clinics of North America, 36(1), 187-200.

Nyitray AG, da Silva RJ C et al, (2011): “Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study”. Journal infectious diseases, 203(1), 49–57.

Vajdic CM, van Leeuwen MT et al (2009): “Anal human papillomavirus genotype diversity and co-infection in a community based sample of homosexual men”. Sexually Transmitted Infections, 85(5), 330–33

Kim JJ (2010): “Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis”. Lancet. Infection diseases, 10(12), 845–852.

Grulich AE, Jin F et al (2010): “Cancers attributable to human papillomavirus infection”. Sex Health, 7(3), 244–252.

Johnson LG, Madeleine MM et al. (2004): “Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000”. Cancer, 101(2), 281-288.

Palefsky JM, Anna R. (2011): “HPV Vaccine against Anal HPV infection and Anal Intraepithelial Neoplasia”. The New England Journal of Medicine, 365(17), 1576-1585.

Chin-Hong PV, Vittinghoff E et al. (2004): “Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study”. Journal Infectious Diseases, 190(12), 2070-6.

Daling JR, Weiss NS et al. (1987): “Sexual practices, sexually transmitted diseases, and the incidence of anal cancer”. New England Journal Medicine, 317(16), 973-7.

Sadlier C, Rowley D, et al. (2014): “Prevalence of human papillomavirus in men who have sex with men in the era of an effective vaccine; a call to act.” HIV medicine, 15(8), 499-504.

Intervenciones para la neoplasia intraepitelial del conducto anal (Revisión Cochrane traducida). Cochrane Database of Systematic Reviews 2012 Issue 12. Art. No.: CD009244. DOI: 10.1002/14651858.CD009244.

Garland SM, Hernandez-Avila M et al. (2007): “Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases”. New England Journal Medicine, 356, 1928–43.

Harper DM, Franco EL, Wheeler CM, et al. (2006): “Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial”. Lancet, 367(9518) ,1247–55.

Smith MA y Canfell K. PLoS One. (2014), Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake. PLoS ONE 9(8): e101048. doi:10.1371 / journal.pone.0101048.

Simatherai D, Bradshaw CS et al. (2009) “What men who have sex with men think about the human papillomavirus vaccine”. Sexually Transmitted Infectious, 85(2), 148–9.

Jane J, Kim PhD. (2010) “A cost-effectiveness analysis of targeted HPV vaccination of men who have sex with men in the United States”. Lancet Infectious Diseases, 10(12), 845–852.

Nadarzynski T, Smith H et al. (2014):”Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review”. Sexually Transmitted infections, 90(7), 515-523.

Pitts MK, Fox C et al. (2007) “What do gay men know about human papillomavirus? Australian gay men's knowledge and experience of anal cancer screening and human papillomavirus”. Sexually Transmitted Disesases, 34(3) ,170–3.

Sanchez DM, Pathela P et al. (2012): “Knowledge of human papillomavirus and anal cancer among men who have sex with men attending a New York City sexually transmitted diseases clinic”. International Journal of STD & AIDS, 23(1), 41–3.

Lau JTF, Wang Z et al. (2013): “Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among men who have sex with men in Hong Kong”. Gray CM, PLoS ONE, 8(2), e57204.

Reiter PL, Brewer NT et al. (2010): “Acceptability of HPV vaccine among a national sample of gay and bisexual men”. Sexually Transmitted Diseases, 37(3), 197–203.

Thomas EA, Goldstone SE. (2011): “Should I or shouldn't I: decision making, knowledge and behavioural effects of quadrivalent HPV vaccination in men who have sex with men”. Vaccine, 29(3), 570–6.

Wheldon CW, Daley EM et al. (2011): “Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States”. Vaccine, 29(45), 8060–5.

Rank C, Gilbert M et al. (2012): “Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs”. Vaccine, 30(39), 5755–60.

Elieen F, Dunne L et al. (2006): “Prevalence of HPV infection among males: a systematic review of the literature”. Journal of infectious diseases. 194(8), 1044-1057.

Zou H, Grulich AE et al. (2014): “How very young men who have sex with men view vaccination against human papillomavirus”. Vaccine, 32(31), 3936-3941.

ACIP recommends all 11-12 year-old males get vaccinated against HPV, (2011, October). CDC Online Newsroom – Press Briefing Transcript. Consulta 10 enero, 2015, de Wold Wide Web: http://www.cdc.gov/media/releases/2011/t1025_hpv_12yroldvaccine.html

European Centre for Disease Prevention and Control (2012). Introduction of HPV vaccines in EU countries – an update. (ISBN 978-92-9193-377-8) Stockholm: ECDC.

The Joint Committee on Vaccination and Immunisation (2014). JCVI interim position statement on HPV vaccination of men who have sex with men (MSM). United Kingdom.

Update On Human Papillomavirus (HPV) Vaccines. (2012, January). Canada Communicable Disease Report. Public Health Agency of Canada. 38(ACS-1). Consulta 10 enero, 2015, de la Wold Wide Web:

http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/12vol38/acs-dcc-1/index-eng.php

Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. 10th ed. Canberra: Australian Government Department of Health, 2013.

Recommended Adult Immunization Schedule, by Vaccine and Age Group (2014). Centers for disease control and prevention. Consulta 11 enero, 2015, de la Word Wide Web: http://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html

Palefksy JM, (2010): “Human Papillomavirus-related disease in men: not just a women’s issue”. The journal of adolescent health: official publication of the Society for Adolescent of Medicine, 46(4), S12-S19.

Public Health Agency of Canada (2014, April). Canadian Immunization Guide. Consulta 11 enero, 2015, de la Wold Wide Web:

http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-hpv-vph-eng.php

Arribas A, Gasco S et al. (2009). Consejería Sanidad Comunidad de Madrid. Papel de Enfermería en Atención Primaria. Plan de mejora de Atención Primaria de la Comunidad de Madrid 2006-2009. Consejería Sanidad Comunidad de Madrid.


Texto completo: HTML

Refbacks

  • No hay Refbacks actualmente.


Bookmark and Share


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

 

ene

 

 

A MC Rosell. El que la conoció no pudo evitar enamorarse de ella.

A Lourdes Álvaro y a su maravillosa historia de amor y lucha. Cuánto espacio se puede ocupar con poco movimiento.

 

 

Creative Commons License Todo el contenido de esta revista, excepto donde está identificado, está bajo una Licencia Creative Commons